{"id":9307,"date":"2021-03-21T00:00:00","date_gmt":"2021-03-21T00:00:00","guid":{"rendered":""},"modified":"2021-03-21T00:00:00","modified_gmt":"2021-03-21T00:00:00","slug":"tralokinumab-does-not-impact-vaccine-induced-immune-responses-results-from-a-30-week-randomized-placebo-controlled-trial-in-adults-with-moderate-to-severe-atopic-dermatitis","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2021\/03\/21\/tralokinumab-does-not-impact-vaccine-induced-immune-responses-results-from-a-30-week-randomized-placebo-controlled-trial-in-adults-with-moderate-to-severe-atopic-dermatitis\/","title":{"rendered":"Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults With Moderate-to-severe Atopic Dermatitis."},"content":{"rendered":"<p>Atopic dermatitis (AD) is a chronic inflammatory skin disease. Interleukin (IL)-13, a type 2 cytokine, is key in AD inflammation. Tralokinumab is a first-in-class, fully human, monoclonal antibody that specifically [&#8230;]\n","protected":false},"excerpt":{"rendered":"<p>Atopic dermatitis (AD) is a chronic inflammatory skin disease. Interleukin (IL)-13, a type 2 cytokine, is key in AD inflammation. Tralokinumab is a first-in-class, fully human, monoclonal antibody that specifically &#8230;<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[86],"tags":[],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/9307"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=9307"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/9307\/revisions"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=9307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=9307"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=9307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}